SP1‐Mediated Glycolytic Reprogramming Promotes Tumorigenesis and Progression in Pancreatic Cancer
Abstract
Research context
OpenAlex topics: Pancreatic and Hepatic Oncology Research · Cancer, Hypoxia, and Metabolism · Epigenetics and DNA Methylation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pancreatic and Metabolic Surgery Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University Nanjing Jiangsu 210008 China
Department of Pathology Nanjing Drum Tower Hospital Affiliated Hospital of Medical School Nanjing University Nanjing Jiangsu 210008 China
Jiangsu Key Laboratory of Molecular Medicine Medical School Nanjing University Nanjing Jiangsu 210093 China
The Affiliated Jiangning Hospital of Nanjing Medical University Nanjing Jiangsu 211100 China
Immunology and Reproduction Biology Laboratory & State Key Laboratory of Analytical Chemistry for Life Science Medical School Nanjing University Nanjing Jiangsu 210093 China
Clinical and Translational Research Center Affiliated Hospital of Nantong University & Department of Oncology Medical School of Nantong University Nantong Jiangsu 226007 China
State Key Laboratory of Pharmaceutical Biotechnology School of life Sciences Nanjing University Nanjing Jiangsu 210023 China
Department of General Visceral and Transplantation Surgery University of Heidelberg 69117 Heidelberg Germany
Chemistry and Biomedicine Innovation Center Institute of Artificial Intelligence Biomedicine Nanjing University Nanjing Jiangsu 210034 China
Institute of Pancreatology Nanjing University Nanjing Jiangsu 210008 China
Funding
National Natural Science Foundation of China · Ministry of Science and Technology of the People's Republic of China